Free Consultations 24/7
Our law firm has been dedicated to clients like you for 90 years. We care about each one of our clients.
Cases We Handle
from auto accidents to defective product injuries to workers’ compensation claims, we’re here to help.
We value building relationships with the many people and organizations that make Cleveland a great place to live.
Our law firm has a trusted team of personal injury lawyers who have been helping injured people in Cleveland.
October 26, 2012
Ohio is set to receive a large portion of a settlement that was reached in connection to a lawsuit filed against drug manufacturing giant, Boehringer Ingelheim Pharmaceuticals Inc. (BIPI). The Dayton Business Journal reports the lawsuit was filed amid allegations the company had engaged in illegal marketing campaigns for certain medications and was also involved in a kickback scheme when it gave millions of dollars to doctors in return for prescribing the company's medications.
Court documents allege that BIPI began to use off-label marketing techniques, or using a drug to treat a condition for which it's not approved. Some of those medications include:
The lawsuit also claims representatives for the company urged doctors to prescribe the medications at higher doses than were approved by the FDA, which could have led to a serious Ohio Drug Injury. The company also is accused of offering doctors incentives for prescribing the drugs to patients.
The settlement in the lawsuit was reached earlier this week and Ohio’s Attorney General, Mike DeWine, says the state should see roughly $1.4 million. The federal government will receive a large chunk of the settlement as well, mainly to cover overpayments that were made to Medicaid.
The Ohio Personal Injury Lawyers with Nurenberg, Paris, Heller & McCarthy are hopeful the settlement will prevent other companies from attempting similar business practices that can put a patient’s health and safety in serious danger.
As advancements in biomedical technology continue to create new opportunities for convenient and painless solutions, more and more products are…
The Journal of the American Medical Association (JAMA) Internal Medicine study, released this month, suggests that doctors should take greater…
Viekira Pak™ and Technivie™ Liver Damage In October, the U.S. Food and Drug Administration (FDA) issued a new warning regarding a potential…